---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-033172"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2026-07-14T20:00:33+00:00"
generated_at: "2026-07-14T20:01:07.095519+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Oncotelic presents corporate presentation to employees; details not available in filing

## Summary
- Presentation given on July 13, 2026 to employees, directors, officers, and advisors.
- No specific financial or operational updates are disclosed in the filing text.
- Exhibit 99.1 (Corporate Presentation) was not provided in the appended text.

## SEC filing metadata
- accession: 0001493152-26-033172
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2026-07-14T20:00:33+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315226033172/0001493152-26-033172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315226033172/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-033172
- JSON: https://secwatch.observer/filing/0001493152-26-033172.json
- Plain text: https://secwatch.observer/filing/0001493152-26-033172.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.